Search results for: 'industrial grade node market'
- Did you mean
- industrial grade nade market
- industrial grade n0de market
- Related search terms
- industrial (robotics decoding) the robotics impact on manufacturing global programmable logic controllers market forecast to 202
- market+size+of+china's+overseas+marketing+industry
- industrial services market global 2030 2025
- industrial services market global 2020 2026
- market 08 00 00 00
-
05 Aug 2025  |  Global  |  Market Research
Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024–2030
Advances in Next-Generation Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth
Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...
$4,950.00 -
07 Sep 2026  |  Global  |  Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Technology Advancements, Clinical Progress, and Growth Opportunities in AI-Enabled Antibody Therapeutics
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion models, and structure-based models are expanding the u...
$4,950.00 -
20 Feb 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Cell & Gene Therapy, Targeted Protein Degradation, Bacteriophage Therapeutics, and Advanced Drug Delivery
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...
$950.00 -
27 May 2016  |  Africa  |  Market Research
Pharmaceutical Market Access Strategy for Ethiopia
Landscaping New Investment Opportunities Across the Pharmaceutical Value Chain
Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 May 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced RNA Therapies, Cancer Vaccines, Immunotherapies, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...
$950.00 -
20 Nov 2017  |  North America  |  Market Research
Global Biologics Market—Companies-to-Action
Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development
This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...
$3,000.00
Special Price $2,250.00 save 25 %
-
05 May 2026  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development & Manufacturing Organizations, Global, 2026–2031
Targeted ADC Upstream and Aseptic Fill-Finish Expansion Expected to Resolve Regional Capacity Gaps and Drive Bio-CDMO Growth
The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...
$2,450.00 -
19 Aug 2025  |  Global  |  Market Research
Emerging Therapeutics for Neurodegenerative Diseases, Global, 2025-2030
Innovative Strategies Driving the Future of Neuro Diseases
This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature o...
$4,950.00 -
27 Apr 2026  |  Global  |  Technology Research
Beyond Chronological Age: Biological Age Tracking and Longevity Platforms
Biological Age Tracking Is Evolving Into a Data-Driven, Multi-Omics, AI-Integrated Paradigm That Enables Precise Measurement of Biomarkers, Risk Assessment, and Longitudinal Health Monitoring
Biological age tracking is emerging as a complementary approach to understanding human health, offering a more nuanced assessment of physiological state than chronological age alone. This report examines the evolving landscape of biological aging platforms, with a focus on molecular and omics-based technologies including epigenetic, proteomic, tran...
$4,950.00 -
19 Sep 2018  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
$4,950.00
Special Price $3,712.50 save 25 %